4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001569926-26-000002
Chief Executive Officer acquired 1,008,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nolan Sean P. · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-12 | Grant or award : show line 1 in the form | +1,008,000 | 3,086,358 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-12 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +648,000 | 648,000 | D |
Loading xslF345X05/form4-01142026_040103.xml…